Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 9, 2000 - Issue 4
Submit an article Journal homepage
105
Views
26
CrossRef citations to date
0
Altmetric
Review

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease

Kelvin A Yamada Department of Neurology, Box 8111, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA. [email protected]
Pages 765-777 | Published online: 24 Feb 2005

  • MONDADORI C: Nootropics: preclinical results in the light of clinical effects; comparison with tacrine. Grit. Rev. Neurobiol. (1996) 10:357–370.
  • VAN REEKUM R, BLACK SE, CONN D, CLARKE, D: Cognition-enhancing drugs in dementia: a guide to the near future. Can" Psychiatr. (1997) 42 (Suppl. 1):35S–50S.
  • ITO I, TANABE S, KOHDA A, SUGIYAMA H: Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J. Physic)]. (1990) 424:533–543.
  • YAMADA KA: Modulating excitatory synaptic neurotransmission: Potential treatment for neurological disease? Neurobiol. Dis. (1998) 5:67–80.
  • KISKIN NI, KRISHTAL OA, TSYNDRENKO AY: Excitatory amino acid receptors in hippocampal neurones: kainate fails to desensitize them. Neurosci. Lett. (1986) 63:225–230.
  • O'DELL TJ, CHRISTENSEN BN: A voltage-clamp study ofisolated stingray horizontal cell non-NMDA excitatory amino acid receptors. J. Neurophysiol. (1989) 61:162–172.
  • MAYER ML, VYKLICKY L, JR.: Concanavalin A selectivelyreduces desensitization of mammalian neuronal quisqualate receptors. Proc. Natl. Acad. ScL USA (1989) 86:1411–1415.
  • THIO LL, CLIFFORD DB, ZORUMSKI CF: Blockade ofionotropic quisqualate receptor desensitization by wheat germ agglutinin in cultured postnatal rat hippocampal neurones. J. Neurophysiol. (1992) 68:1917–1929.
  • ZORUMSKI CF, THIO LL: Properties of vertebrateglutamate receptors: calcium mobilization and desensitization. Prog. Neurobiol (1992) 39:295–336.
  • ZORUMSKI CF, MENNERICK SJ: Desensitization and theshort-term modulation of AMPA/Kainate receptors in vertebrate neurones. In: Direct and Allosteric Control of Glutamate Receptors. Palfreyman MG, Reynolds IJ, Skolnick P (Eds.) CRC Press, Boca Raton, Florida, USA. (1994):57–75.
  • ARAI A, LYNCH G: Factors regulating the magnitude oflong-term potentiation induced by theta pattern stimulation. Brain Res. (1992) 598:173–184.
  • ARAI A, KESSLER M, ROGERS G, LYNCH G: Effects of amemory-enhancing drug on DL-alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus. J. Pharmacol. Exp. Ther. (1996) 278:627–638.
  • GRANGER R, STAUBLI U, DAVIS M et al: A drug that facili-tates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task. Synapse (1993) 15:326–329.
  • INGVAR M, AMBROS-INGERSON J, DAVIS M et al.:Enhancement by an ampakine of memory encoding in humans. Exp. Neurol (1997) 146:553–559.
  • STAUBLI U, ROGERS G, LYNCH G: Facilitation ofglutamate receptors enhances memory. Proc. Natl. Acad. ScL USA (1994) 91:777–781.
  • LYNCH G, GRANGER R, AMBROS-INGERSON J, DAVIS CM,KESSLER M, SCHEHR R: Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans. Exp. Neurol (1997) 145:89–92.
  • •Human experiments with ampakine CX516.
  • HAMPSON RE, ROGERS G, LYNCH G, DEADWYLER SA:Facilitative effects of the ampakine cx516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance. J. Neurosci. (1998) 18:2740–2747.
  • HAMPSON RE, ROGERS G, LYNCH G, DEADWYLER SA:Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity. J. Neurosci. (1998) 18:2748–2763.
  • LYNCH G: Memory and the brain: unexpected chemis- tries and a new pharmacology. Neurobiol. Learn. Mem. (1998) 70:82–100.
  • ••Review including ampakine modulators.
  • YAMADA KA, ROTHMAN SM: Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurones. J. Physiol (1992) 458:385–407.
  • TANG C-M, SHI Q-Y, KATCHMAN A, LYNCH G: Modula-tion of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science (1991) 254:288–290.
  • ISAACSON JS, NICOLL RA: Aniracetam reducesglutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc. Natl. Acad. ScL USA (1991) 88:10936–10940.
  • YAMADA KA, TANG C-M: Benzothiadiazides inhibitrapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. NeuroscL (1993) 13:3904–3915.
  • YAMADA KA: Structure-activity determinants of pharmacological modulation of AMPA receptors. In: Pharmacology of Cerebral Ischaemia. Krieglstein J (Ed.), Medpharm Scientific Publishers, Stuttgart, Germany (1996):625–638.
  • BERTOLINO M, BARALDI M, PARENTI C etal.: Modulation of AMPA/Kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels (1993) 1:267–278.
  • ZIVKOVIC I, THOMPSON DM, BERTOLINO M et al.: 7-Chloro-3-methy1-3-4-dihydro-211-1,2,4 benzothiadi-azine S,S- dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3- oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitiza-tion. J. Pharmacol. Exp. Ther. (1995) 272:300–309.
  • UZUNOV DP, ZIVKOVICH I, PIRKLE WH, COSTA E, GUIDOTTI A: Enantiomeric resolution with a new chiral stationary phase of 7-chloro-3-methy1-3,4-dihydro-211-1,2,4-benzothiadiazine S,S-dioxide, a cognition-enhancing benzothiadiazine derivative. J. Pharm. Sci. (1995) 84:937–942.
  • THOMPSON DM, GUIDOTTI A, DIBELLA M, COSTA E: 7-Chloro- 3 -methyl- 3, 4 -dihydro- 21-1-1, 2, 4-benzothiadiazine S,S- dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys. Proc. Natl. Acad. Sci. USA (1995) 92:7667–7671.
  • SEKIGUCHI M, FLECK MW, MAYERML et al.: A novel allosteric potentiator of AMPA receptors: 4-2-(phenylsulfonylamino)ethylthio-2,6-difluoro-phenoxyaceta mide. j NeuroscL (1997) 17:5760–5771.
  • VIZI ES, MIKE A, TARNAWA I: 2,3-benzodiazepines[GYKI 52466 and analogs]: negative allosteric modulators of AMPA receptors. CNS Drug Reviews (1996) 2:91–126.
  • FLETCHER EJ, LODGE D: New developments in the molecular pharmacology of alpha-amino-3- hydroxy- 5-methy1-4-isoxazole propionate and kainate receptors. Pharmacol. Ther. (1996) 70:65–89.
  • HOLLMANN M, O'SHEA-GREENFIELD A, ROGERS SW, HEINEMANN S: Cloning by functional expression of a member of the glutamate receptor family. Nature (1989) 342:643–648.
  • KEINANEN K, WISDEN W, SOMMER B et al.: A family ofAMPA-selective glutamate receptors. Science (1990) 249:556–560.
  • SOMMER B, KEINANEN K, VERDOORN TA et al: Flip andflop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science (1990) 249:1580–1585.
  • WERNER P, VOIGT M, KEINANEN K, WISDEN W, SEEBURG PH: Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature (1991) 351:742–744.
  • BETTLER B, BOULTER J, HERMANS-BORGMEYER I et al.: Cloning of a novel glutamate receptor subunit, G1uR5: expression in the nervous system during develop-ment. Neuron (1990) 5:583–595.
  • DINGLEDINE R, BORGES K, BOWIE D, TRAYNELIS SF: Theglutamate receptor ion channels. Pharmacol. Rev. (1999) 51:7–61.
  • WONG LA, MAYER ML: Differential modulation by cyclothiazide and concanavalin A of desensitization at native alpha-amino-3-hydroxy-5-methyl-4- isoxazole-propionic acid- and kainate-preferring glutamate receptors. Mol. Pharmacol. (1993) 44:504–510.
  • PARTIN KM, PATNEAU DK, WINTERS CA, MAYER ML, BUONANNO A: Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavilin A. Neuron (1993) 11:1069–1082.
  • PARTIN KM, PATNEAU DK, MAYER ML: Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methy1-4-isoxazolepropionic acid receptor splice variants. MoL Pharmacol. (1994) 46:129–138.
  • ARAI A, KESSLER M, AMBROS-INGERSON J et al.: Effects ofa centrally active benzoylpyrrolidine drug on AMPA receptor kinetics. Neuroscience (1996) 75:573–585.
  • •Physiological effects of ampakines.
  • ARAI A, LYNCH G: The waveform of synaptic transmis-sion at hippocampal synapses is not determined by AMPA receptor desensitization. Brain Res. (1998) 799:230–234.
  • MOSBACHER J, SCHOEPFER R, MONYER H, BURNASHEVN, SEEBURG PH, RUPPERSBERG JP: A molecular determi-nant for submillisecond desensitization in glutamate receptors. Science (1994) 266:1059–1062.
  • PARTIN KM, BOWIE D, MAYER ML: Structural determi-nants of allosteric regulation in alternatively spliced AMPA receptors. Neuron (1995) 14:833–843.
  • PARTIN KM, FLECK MW, MAYER ML: AMPA receptor flip/flop mutants affecting deactivation, desensitization and modulation by cyclothiazide, aniracetam and thiocyanate. J. Neurosci. (1996) 16:6634–6647.
  • ••Important paper exploring moelcular determinants ofallosteric modulation of AMPA receptors by different classes of modulatory drugs.
  • BLISS TV, LOMO T: Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. (1973) 232:331–356.
  • BLISS TV, COLLINGRIDGE GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 361:31–39.
  • ARAI A, GUIDOTTI A, COSTA E, LYNCH G: Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices. Neuroreport (1996) 7:2211–2215.
  • STAUBLI U, PEREZ Y, XU FB et al.: Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc. Natl. Acad. Sci. USA (1994) 91:11158–11162.
  • SIRVIO J, LARSON J, QUACH CN, ROGERS GA, LYNCH G:Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit. Neuroscience (1996) 74:1025–1035.
  • CALESNICK B, KATCHEN B, BLACK J: Importance of dissolution rates in producing effective diazoxide blood levels in man. J. Pharm. Sci. (1965) 54:1277–1280.
  • YAMADA KA, HILL MW, HU Y, COVEY DF: The diazoxidederivative 7-chloro-2-methyl-3,4-dihydro-211-1,2, 4-benzothiadiazine-S,S-dioxide (IDRA21) augments AMPA and GABA mediated synaptic responses in cultured hippocampal neurones. Neurobiol Dis. (1998) 5:196–205.
  • LARSON J, LIEU T, PETCHPRADUB et al: Facilitation ofolfactory learning by a modulator of AMPA receptors. Neurosci. (1995) 15:8023–8030.
  • LYNCH G, KESSLER M, ROGERS G, AMBROS-INGERSON J, GRANGER R, SCHEHR RS: Psychological effects of a drug that facilitates brain AMPA receptors. Int. Clin. Psycho-pharmacol. (1996) 11:13–19.
  • TSIEN JZ, HUERTA PT, TONEGAWA S: The essential role of hippocampal CA1 nmda receptor-dependent synaptic plasticity in spacial memory. Cell (1996) 87:1327–1338.
  • ZAMANILLO D, SPRENGEL R, HVALBY 0 et al.:Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science (1999) 284:1805–1811.
  • BAHR BA, TIRIVEEDHI S, PARK GY, LYNCH G: Inductionof calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J. Pharmacol. Exp. Ther. (1995) 273:902–908.
  • YAMADA KA: The physiological and pathophysio-logical importance of rapid glutamate receptor desensitization. Annual Meeting of the Child Neurology Society. New Orleans, USA. (1992) Ann. Neurol. 32: 419.
  • TRESCHER WH: Cyclothiazide-induced hippocampalinjury in immature rat brain. Annual Meeting of the Child Neurology Society Minneapolis, USA. (1996) Ann. Neurol 40:288.
  • MOUDY AM, YAMADA KA, ROTHMAN SM: Rapid desensitization determines the pharmacology of glutamate neurotoxicity. Neuropharmacology (1994) 33:953–962.
  • MAY PC, ROBISON PM: Cyclothiazide treatmentunmasks AMPA excitotoxicity in rat primary hippocampal cultures. J. Neurochem. (1993) 60:1171–1174.
  • MAY PC, ROBISON PM: GYKI 52466 protects againstnon-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures. Neurosci. Lett. (1993) 152:169–172.
  • DAVID JC, YAMADA KA, BAGWE MR, GOLDBERG MP: AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. J. Neurosci. (1996) 16:200–209.
  • PELLEGRINI-GIAMPIETRO DE, ZUKIN RS, BENNETT MVL, CHO S, PULSINELLI WA: Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc. Natl. Acad. Sci. USA (1992) 89:10499–10503.
  • GORTER JA, PETROZZINO JJ, ARONICA EM et al.: Global ischemia induces downregulation of Glur2 mRNA and increases AMPA receptor-mediated Ca2+ influx in hippocampal CA1 neurones of gerbil. J. Neurosci. (1997) 17:6179–6188.
  • PELLEGRINI-GIAMPIETRO DE, GORTER JA, BENNETT MV, ZUKIN RS: The G1uR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. (1997) 20:464–470.
  • IMPAGNATIELLO F, OBERTO A, LONGONE P, COSTA E, GUIDOTTI A: 7-Chloro-3-methyl-3,4-dihydro-211-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicity. Proc. Arad Acad. Sci. USA (1997) 94:7053–7058.
  • YAMADA KA, COVEY DF, HSU CY, HU R, HU Y, HE YY:The diazoxide derivative IDRA 21 enhances ischemic hippocampal neuron injury. Ann. Neurol (1998) 43:664–669.
  • •Potential toxicity of AMPA modulators in in vivo global ischaemia model.
  • YAMADA KA: AMPA receptor activation potentiated by the AMPA modulator 1-BCP is toxic to cultured rat hippocampal neurones. Neurosci. Lett. (1998) 249:119–122.
  • LAUTERBORN JC, LYNCH G, VANDERKLISH P, ARM A, GALL CM: Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurones. J. Neurosci. (2000) 20:8–21.
  • SHEARDOWN MJ, NIELSEN EO, HANSEN AJ, JACOBSEN P, HONORE T: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science (1990) 247:571–574.
  • BUCHAN AM, LI H, CHO S, PULSINELLI WA: Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci. Lett. (1991) 132:255–258.
  • NELLGARD B, WIELOCH T: Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia. J. Cereb. Blood Flow Metab. (1992) 12:2–11.
  • OLNEY JW, NEWCOMER JW, FARBER NB: NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. (1999) 33:523–533.
  • JOHNSON SA, LUU NT, HERBST TA et al.: Synergistic interactions between ampakines and antipsychotic drugs. J. Pharmacol Exp. Ther. (1999) 289:392–397.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.